about
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumorsBayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in ratsApplications of nanotechnology in dermatologyGold nanoprobes for theranosticsState of academic knowledge on toxicity and biological fate of quantum dotsTherapeutic efficacy of nanomedicines for prostate cancer: An updateBiological interactions of carbon-based nanomaterials: From coronation to degradation.Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesGold nanoparticle contrast agents in advanced X-ray imaging technologiesNanoparticle-facilitated functional and molecular imaging for the early detection of cancerUpconversion nanoparticles: design, nanochemistry, and applications in theranosticsCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Bench-to-bedside translation of magnetic nanoparticlesNanoemulsions in translational research-opportunities and challenges in targeted cancer therapyPhysicochemical characteristics of nanomaterials that affect pulmonary inflammationEngineered nanomaterial uptake and tissue distribution: from cell to organismNanoparticle contrast agents for computed tomography: a focus on micellesQuantum dots as a platform for nanoparticle drug delivery vehicle designImproving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?Therapeutic targeting of liver inflammation and fibrosis by nanomedicinePerspectives in Biological Monitoring of Inhaled Nanosized ParticlesNanotechnology in cancer therapyVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmGadolinium-based nanoparticles for theranostic MRI-radiosensitizationOptical and electron microscopy study of laser-based intracellular molecule delivery using peptide-conjugated photodispersible gold nanoparticle agglomerates.Optical nano antennas: state of the art, scope and challenges as a biosensor along with human exposure to nano-toxicologyGold nanoparticles for cancer radiotherapy: a reviewLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaIntraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions.PEGylated Human Serum Albumin: Review of PEGylation, Purification and Characterization MethodsNanoparticles in magnetic resonance imaging: from simple to dual contrast agentsPharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesPositron emission tomography imaging using radiolabeled inorganic nanomaterialsDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersSTED microscopy and its applications: new insights into cellular processes on the nanoscaleDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersToxicity of nanomaterialsGestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthoodCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesHyperthermia using nanoparticles--Promises and pitfalls.
P2860
Q21245468-E8CE99B7-D22F-4E84-B7F9-0E49905DCA1AQ23917058-89F97ADF-F125-4787-A320-3735D1B2D47DQ24170384-D2D1B399-F0DD-4E82-A87B-2AD46AC929DEQ24629197-D9901B4C-AEEA-47C9-A520-5272CE196A70Q24656654-062E3B18-8C80-4C94-BA45-3933637F8BD4Q26766305-778BE053-D58D-435B-B142-4F0FD6661500Q26771906-FFFFBCEC-B9C3-465B-821D-F9A4995C877AQ26798426-7B996EAD-FF29-4104-BF16-6ED3AEF52667Q26825775-D833B39D-53A8-4DBA-A56F-BBFAB8B82416Q26828849-3D21EC42-BFC6-4BD7-B01B-F1A5A3C36D16Q26830008-33DCFA81-D2C9-4958-B95B-E66949D899B5Q26830028-3FF15D86-960A-49FF-BBD4-FC4F82B044A7Q26850547-F935564D-1CD2-444E-8828-6D8B55EFCEE0Q26858849-FFF6C154-A9A6-4A7D-A794-A49EC998B31EQ26859438-FAB3A343-D0E4-4FA0-847D-29324C2DD84DQ26861914-58D78FCA-9D5F-4AD3-88F7-DFE34F8EBE4FQ26863316-694990C4-5553-409F-9696-133D8314334CQ26996556-864F0F96-3BD3-4CC4-9BF0-377DCF7C1F6BQ26999332-690CDDD7-5BCB-456C-8BC6-F4890A4C42FFQ27000074-B8D3BE61-DBAF-4754-8905-2C0B0B53133CQ27000730-AACCC861-B742-435C-867B-B8D31B936441Q27023013-742A8EEF-1D76-434D-AEFE-F061BFA994D5Q27026630-C2FF0103-C659-442A-832D-308E81761058Q27027308-B001E2C5-6B0B-4F00-BB1C-21468A930902Q27304201-F452209F-643D-4BDD-83AE-E9CEB03D0A94Q27691325-87DB3361-774E-4DD3-96CA-38A104AC1DD1Q28066413-981B9A78-75B6-46D7-9BB3-7C3E532F32F3Q28068437-5C7061C3-6B12-47BB-9136-9688FE8CB72EQ28073893-0E6B9FB3-5AA4-4CE2-9BED-C3C53F17D799Q28076027-1B283918-58DA-4BDA-A929-5FD8B5B09AC3Q28082690-DCA58113-B686-40EC-B785-04D235902493Q28084443-F43321B9-BBE9-46A2-B423-7CA447ED3E05Q28085340-33789C9B-4DF8-4A43-A22D-A4FE986057F1Q28235682-9CBCA219-D180-46EB-97C9-4DAFAEA5B670Q28260935-FF841997-5BDC-4A5C-A861-FB5509E00279Q28283802-42308B01-2624-4F0D-850F-0BEC770ED672Q28383168-39AD5B09-41DB-4D42-8A4A-997317575736Q28383364-0AECFDC6-5B69-4F20-8E21-DEC6783B337CQ28383937-77CA98B2-FDB2-4C56-BEA6-314DAA7632B7Q28384618-88A530C4-E965-4CD8-A9B0-09353F7EB8D7
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Renal clearance of quantum dots
@nl
Renal clearance of quantum dots.
@ast
Renal clearance of quantum dots.
@en
type
label
Renal clearance of quantum dots
@nl
Renal clearance of quantum dots.
@ast
Renal clearance of quantum dots.
@en
prefLabel
Renal clearance of quantum dots
@nl
Renal clearance of quantum dots.
@ast
Renal clearance of quantum dots.
@en
P2093
P2860
P921
P3181
P356
P1433
P1476
Renal clearance of quantum dots.
@en
P2093
Binil Itty Ipe
Eiichi Tanaka
Hak Soo Choi
John P Zimmer
Preeti Misra
Wenhao Liu
P2860
P2888
P304
P3181
P356
10.1038/NBT1340
P407
P577
2007-09-23T00:00:00Z
P5875
P6179
1046807591